Stifel Financial
SPRY icon

Stifel Financial’s ARS Pharmaceuticals SPRY Stock Holding History

Stifel Financial’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,392
Closed -$234K – 3640
2025
Q2 		$234K Buy
13,392
+21
+0.2% +$303 ﹤0.01% 3185
2025
Q1 		$168K Sell
13,371
-388
-3% -$4.67K ﹤0.01% 3218
2024
Q4 		$145K Buy
13,759
+13
+0.1% +$182 ﹤0.01% 3212
2024
Q3 		$199K Buy
+13,746
New +$163K ﹤0.01% 3147
2023
Q3 		– Sell
-12,327
Closed -$82.6K – 3398
2023
Q2 		$82.6K Buy
+12,327
New +$82.3K ﹤0.01% 3194

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return